Total Clarity Wealth Management’s Champions Oncology CSBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-937
Closed -$7K 364
2022
Q2
$7K Buy
+937
New +$7.17K ﹤0.01% 742
2021
Q4
Sell
-713
Closed -$7K 996
2021
Q3
$7K Buy
+713
New +$7.25K ﹤0.01% 750
2021
Q2
Sell
-713
Closed -$8K 299
2021
Q1
$8K Buy
+713
New +$8.28K ﹤0.01% 595

Other funds holding CSBR

Total Clarity Wealth Management's CSBR Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Champions Oncology (CSBR) in Q3 2022, closing a stake of 937 shares — an estimated $7K sold.

Total Clarity Wealth Management first reported a position in CSBR in Q1 2021 and held it in 3 quarters. The position peaked at $8K in Q1 2021. 32 funds tracked by Wall St. Rank hold CSBR as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Champions Oncology position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 937 Champions Oncology shares in Q3 2022, an estimated $7K.
  • Total Clarity Wealth Management first reported a position in Champions Oncology in Q1 2021 and held it in 3 quarters.
  • Total Clarity Wealth Management's Champions Oncology position peaked at $8K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.